About: Oncolytic AAV

An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Adeno-associated virus (AAV) has been researched as a viral vector in gene therapy for cancer treatment as an Oncolytic Virus. Currently there are not any FDA approved AAV cancer treatments, as the first FDA approved AAV treatment was approved December 2017. However, there are many Oncolytic AAV applications that are in development and have been researched.

Property Value
dbo:abstract
  • Adeno-associated virus (AAV) has been researched as a viral vector in gene therapy for cancer treatment as an Oncolytic Virus. Currently there are not any FDA approved AAV cancer treatments, as the first FDA approved AAV treatment was approved December 2017. However, there are many Oncolytic AAV applications that are in development and have been researched. (en)
dbo:wikiPageID
  • 57153278 (xsd:integer)
dbo:wikiPageLength
  • 10216 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1101820957 (xsd:integer)
dbo:wikiPageWikiLink
dbp:date
  • August 2022 (en)
dbp:talkPageSectionName
  • AAV is a non-lytic virus; thus the phrase "oncolytic AAV" is an oxymoron. (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdfs:comment
  • Adeno-associated virus (AAV) has been researched as a viral vector in gene therapy for cancer treatment as an Oncolytic Virus. Currently there are not any FDA approved AAV cancer treatments, as the first FDA approved AAV treatment was approved December 2017. However, there are many Oncolytic AAV applications that are in development and have been researched. (en)
rdfs:label
  • Oncolytic AAV (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License